Literature DB >> 14656437

Crystal structure of the human myeloid cell activating receptor TREM-1.

Sergei Radaev1, Michael Kattah, Bertha Rostro, Marco Colonna, Peter D Sun.   

Abstract

Triggering receptors expressed on myeloid cells (TREM) are a family of recently discovered receptors that play important roles in innate immune responses, such as to activate inflammatory responses and to contribute to septic shock in response to microbial-mediated infections. To date, two TREM receptors in human and several homologs in mice have been identified. We report the 2.6 A resolution crystal structure of the extracellular domain of human TREM-1. The overall fold of the receptor resembles that of a V-type immunoglobulin domain with differences primarily located in the N-terminal strand. TREM-1 forms a "head-to-tail" dimer with 4100 A(2) interface area that is partially mediated by a domain swapping between the first strands. This mode of dimer formation is different from the "head-to-head" dimerization that existed in V(H)V(L) domains of antibodies or V domains of T cell receptors. As a result, the dimeric TREM-1 most likely contains two distinct ligand binding sites.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14656437     DOI: 10.1016/j.str.2003.11.001

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  29 in total

Review 1.  Triggering receptor expressed on myeloid cells receptor family modulators: a patent review.

Authors:  Christopher J Pelham; Amit N Pandya; Devendra K Agrawal
Journal:  Expert Opin Ther Pat       Date:  2014-11-01       Impact factor: 6.674

2.  Structural and functional studies of Igalphabeta and its assembly with the B cell antigen receptor.

Authors:  Sergei Radaev; Zhongcheng Zou; Pavel Tolar; Khanh Nguyen; AnhThao Nguyen; Peter D Krueger; Nicole Stutzman; Susan Pierce; Peter D Sun
Journal:  Structure       Date:  2010-08-11       Impact factor: 5.006

3.  Identification of a Novel Splice Variant Isoform of TREM-1 in Human Neutrophil Granules.

Authors:  Sankar Baruah; Kathy Keck; Michelle Vrenios; Marshall R Pope; Merideth Pearl; Kevin Doerschug; Julia Klesney-Tait
Journal:  J Immunol       Date:  2015-11-11       Impact factor: 5.422

4.  Novel immunoglobulin-like transcripts in teleost fish encode polymorphic receptors with cytoplasmic ITAM or ITIM and a new structural Ig domain similar to the natural cytotoxicity receptor NKp44.

Authors:  René J M Stet; Trudi Hermsen; Adrie H Westphal; Jojanneke Jukes; Marc Engelsma; B M Lidy Verburg-van Kemenade; Jos Dortmans; Joao Aveiro; Huub F J Savelkoul
Journal:  Immunogenetics       Date:  2005-02-09       Impact factor: 2.846

5.  Modulation of the triggering receptor expressed on the myeloid cell type 1 pathway in murine septic shock.

Authors:  Sébastien Gibot; Cecilia Buonsanti; Frédéric Massin; Michele Romano; Marie-Nathalie Kolopp-Sarda; Fabio Benigni; Gilbert C Faure; Marie-Christine Béné; Paola Panina-Bordignon; Nadia Passini; Bruno Lévy
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

6.  Triggering receptor in myeloid cells (TREM-1) specific expression in peripheral blood mononuclear cells of sepsis patients with acute cholangitis.

Authors:  Rui Liao; Zuojin Liu; Sidong Wei; Faliang Xu; Zhenzhen Chen; Jianping Gong
Journal:  Inflammation       Date:  2009-06       Impact factor: 4.092

7.  The SCHOOL of nature: I. Transmembrane signaling.

Authors:  Alexander B Sigalov
Journal:  Self Nonself       Date:  2010-01

8.  The SCHOOL of nature: III. From mechanistic understanding to novel therapies.

Authors:  Alexander B Sigalov
Journal:  Self Nonself       Date:  2010-06-11

Review 9.  Soluble triggering receptor expressed on myeloid cell-1 (sTREM-1): a potential biomarker for the diagnosis of infectious diseases.

Authors:  Changlin Cao; Jingxian Gu; Jingyao Zhang
Journal:  Front Med       Date:  2017-04-19       Impact factor: 4.592

10.  Activation of the TREM-1 pathway in human monocytes by periodontal pathogens and oral commensal bacteria.

Authors:  M Varanat; E M Haase; J G Kay; F A Scannapieco
Journal:  Mol Oral Microbiol       Date:  2016-09-06       Impact factor: 3.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.